Recombinant Human Erythropoietin Alfa from Japan
A biotechnologically produced hematopoietin stimulating red blood cell production, used in anemia treatment for chronic kidney disease patients. Classified in HTS 3002.90.52.50 as an immunological product (hematopoietin) for therapeutic use. It is a growth factor directly involved in blood cell regulation.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit purity assays and isoform profiles for FDA potency verification
• Package in pre-filled syringes with tamper-evident seals for import inspection
• Confirm not waste pharmaceuticals unfit for use per Chapter 30 note 6(k)